Skip to content
World Egg Organisation
  • Become a Member
  • Login
  • Home
  • Who We Are
    • Vision, Mission & Values
    • Our History
    • WEO Leadership
    • WEO Family Tree 
    • Member Directory 
    • WEO Support Group
  • Our Work
    • HPAI Support Hub
    • Vision 365
    • World Egg Day
    • Young Egg Leaders
    • WEO Awards
    • Industry Representation
    • Egg Nutrition
    • Egg Sustainability
  • Our Events
    • WEO Global Leadership Conference Cartagena 2025
    • Future WEO Events
    • Previous WEO Events
    • Other Industry Events
  • Resources
    • News Updates
    • Presentations 
    • Country Insights 
    • Cracking Egg Nutrition
    • Downloadable Resources
    • Chick Placements 
    • Interactive Statistics 
    • Publications 
    • Scientific Library 
    • Industry Guidelines, Positions, and Responses 
  • Contact
  • Become a Member
  • Login
Home > Resources > Scientific Library > Human Nutrition > Horrocks, 1999 – Health Benefits of Docosahexaenoic Acid (DHA)
  • Resources
  • News Updates
  • Presentations 
  • Country Insights 
  • Interactive Statistics 
  • Chick Placements 
  • Downloadable Resources
  • Cracking Egg Nutrition
  • WEO Publications 
  • Scientific Library 
  • Industry Guidelines, Positions, and Responses 

Horrocks, 1999 – Health Benefits of Docosahexaenoic Acid (DHA)

Docosahexaenoic acid (DHA) is essential for the growth and functional development of the brain in infants. DHA is also required for maintenance of normal brain function in adults. The inclusion of plentiful DHA in the diet improves learning ability, whereas deficiencies of DHA are associated with deficits in learning. DHA is taken up by the brain in preference to other fatty acids. The turnover of DHA in the brain is very fast, more so than is generally realized. The visual acuity of healthy, full-term, formula-fed infants is increased when their formula includes DHA. During the last 50 years, many infants have been fed formula diets lacking DHA and other omega-3 fatty acids. DHA deficiencies are associated with foetal alcohol syndrome, attention deficit hyperactivity disorder, cystic fibrosis, phenylketonuria, unipolar depression, aggressive hostility, and adrenoleukodystrophy. Decreases in DHA in the brain are associated with cognitive decline during aging and with onset of sporadic Alzheimer disease. The leading cause of death in western nations is cardiovascular disease. Epidemiological studies have shown a strong correlation between fish consumption and reduction in sudden death from myocardial infarction. The reduction is approximately 50% with 200 mg dayy1 of DHA from fish. DHA is the active component in fish. Not only does fish oil reduce triglycerides in the blood and decrease thrombosis, but it also prevents cardiac arrhythmias. The association of DHA deficiency with depression is the reason for the robust positive correlation between depression and myocardial infarction. Patients with cardiovascular disease or Type II diabetes are often advised to adopt a low-fat diet with a high proportion of carbohydrate. A study with women shows that this type of diet increases plasma triglycerides and the severity of Type II diabetes and coronary heart disease. DHA is present in fatty fish, salmon, tuna, mackerel and mother’s milk. DHA is present at low levels in meat and eggs, but is not usually present in infant formulas. EPA, another long-chain n-3 fatty acid, is also present in fatty fish. The shorter chain n-3 fatty acid, a-linolenic acid, is not converted very well to DHA in man. These long-chain n-3 fatty acids also known as omega-3 fatty acids are now becoming available in some foods, especially infant formula and eggs in Europe and Japan. Fish oil decreases the proliferation of tumour cells, whereas arachidonic acid, a longchain n-6 fatty acid, increases their proliferation. These opposite effects are also seen with inflammation, particularly with rheumatoid arthritis, and with asthma. DHA has a positive effect on diseases such as hypertension, arthritis, atherosclerosis, depression, adult-onset diabetes mellitus, myocardial infarction, thrombosis, and some cancers.

Download Now

Stay Updated

Want to gain the latest news from the WEO and updates on our events? Sign up to the WEO Newsletter.

    • Terms and Conditions
    • Privacy Policy
    • Disclaimer
    • Become a Member
    • Contact
    • Careers

UK Administration Office

P: +44 (0) 1694 723 004

E: info@worldeggorganisation.com

  • Linkedin
  • Instagram
  • Facebook
  • X
  • YouTube
Site by web and creative agencyeighteen73

Search

Select A Language